ENTRY       D12585            Mixture   Drug
NAME        Adsorbed diphtheria-purified pertussis-tetanus-inactivate polio-haemophilus type b conjugate combined vaccine;
            Gobik (TN);
            Quintovac (TN)
COMPONENT   Bordetella pertussis defense antigen, Diphtheria toxoid [DR:D03926], Tetanus toxoid adsorbed [DR:D05316], Inactivated poliovirus, Haemophilus influenzae type b oligosaccharide
REMARK      Therapeutic category: 6361
            ATC code: J07CA05
            Product: D12585<JP>
EFFICACY    Active immunization
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J07 VACCINES
               J07C BACTERIAL AND VIRAL VACCINES, COMBINED
                J07CA Bacterial and viral vaccines, combined
                 J07CA05 Diphtheria-hepatitis b-pertussis-tetanus
                  D12585  Adsorbed diphtheria-purified pertussis-tetanus-inactivate polio-haemophilus type b conjugate combined vaccine &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               636  Mixed biological preparations
                6361  Vaccine and toxoid mixtures
                 D12585  Adsorbed diphtheria-purified pertussis-tetanus-inactivate polio-haemophilus type b conjugate combined vaccine
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D12585
///
